We propose to solve the credibility problem by assigning each scientific report a simple measure of veracity, the R-factor, with R standing for reputation, reproducibility, responsibility, and robustness
The R-factor is calculated by dividing the number of studies that confirmed a claim by the total number of attempts to verify it.
Sean Rife, co-founder and Director of Research, is an Assistant Professor of Psychology at
Murray State University. He holds a PhD in psychology (minor in quantitative
methods) from Kent State University. Sean has developed numerous software packages
related to research in the social sciences, and has recently focused his
attention on the application of machine-learning algorithms to social science
research. He is a strong advocate of open science, and a founding member of the
Society for the Improvement of Psychological Science.
Yuri Lazebnik, co-founder and CEO, has 35 years of experience in cancer research
at the intersection of several disciplines. He holds a PhD in biochemistry
and did his research at Johns Hopkins University, Cold Spring Harbor
Laboratory, where he directed a cutting-edge research laboratory for 18 years, and
Yale University. Yuri has also been advocating engineering approaches in biology and has questioned the prevalent view on what
causes the malaise of biomedical research.
co-founder and Director of Business Development, received his Ph.D. in 2015
from Virginia Tech studying how aneuploidy affects chromosome segregation in
cancer cells. He founded the Winnower, an open publishing platform for
researchers in 2014 to improve how research is published and is
now chief research officer at Authorea, a collaborative editor for researchers
to write and disseminate research reports.
Grabitz, co-founder and Director of Outreach and Community Engagement, likes to rethink established structures in research. His passions revolve around access to knowledge and to medicines. He works with the Science Lab at Mozilla Foundation, where he mentors Open Science related projects. Moreover, Peter serves as European Coordinator for Universities Allied for Essential Medicines, a students network advocating for access to medicines around the world. While finishing medical school in Germany he researches citation networks in cancer drug development and develops new ways of visualizing relations between scientific publications.